Ancora Advisors LLC cut its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 23.6% during the third quarter, HoldingsChannel.com reports. The firm owned 11,351 shares of the company’s stock after selling 3,510 shares during the quarter. Ancora Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $430,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. GSA Capital Partners LLP bought a new position in shares of Prestige Consumer Healthcare during the third quarter valued at approximately $561,000. Standard Life Aberdeen plc grew its stake in shares of Prestige Consumer Healthcare by 6.3% during the third quarter. Standard Life Aberdeen plc now owns 1,094,907 shares of the company’s stock valued at $41,492,000 after buying an additional 65,155 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Prestige Consumer Healthcare by 13.4% during the third quarter. Dimensional Fund Advisors LP now owns 3,629,692 shares of the company’s stock valued at $137,530,000 after buying an additional 429,978 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of Prestige Consumer Healthcare by 2.9% during the third quarter. Bank of New York Mellon Corp now owns 671,871 shares of the company’s stock valued at $25,457,000 after buying an additional 19,028 shares during the last quarter. Finally, Janus Henderson Group PLC grew its stake in shares of Prestige Consumer Healthcare by 1.7% during the third quarter. Janus Henderson Group PLC now owns 959,215 shares of the company’s stock valued at $36,345,000 after buying an additional 16,173 shares during the last quarter.
In related news, EVP Timothy Connors sold 34,000 shares of the stock in a transaction that occurred on Monday, November 19th. The stock was sold at an average price of $38.25, for a total value of $1,300,500.00. Following the transaction, the executive vice president now owns 25,775 shares of the company’s stock, valued at $985,893.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.14% of the stock is owned by corporate insiders.
PBH has been the topic of a number of analyst reports. ValuEngine raised Prestige Consumer Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, November 7th. Zacks Investment Research reissued a “hold” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, November 14th. Finally, DA Davidson increased their price objective on Prestige Consumer Healthcare to $38.00 and gave the stock a “neutral” rating in a research note on Monday, November 5th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $39.67.
Shares of NYSE:PBH opened at $36.82 on Thursday. Prestige Consumer Healthcare Inc has a 52-week low of $27.84 and a 52-week high of $47.90. The company has a market capitalization of $2.01 billion, a P/E ratio of 14.27, a PEG ratio of 1.89 and a beta of 1.01. The company has a current ratio of 2.15, a quick ratio of 1.38 and a debt-to-equity ratio of 1.59.
Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, November 1st. The company reported $0.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.02. Prestige Consumer Healthcare had a return on equity of 11.82% and a net margin of 33.38%. The company had revenue of $239.36 million for the quarter, compared to analysts’ expectations of $236.28 million. During the same quarter in the prior year, the firm earned $0.61 earnings per share. Prestige Consumer Healthcare’s revenue was down 7.2% compared to the same quarter last year. As a group, equities research analysts predict that Prestige Consumer Healthcare Inc will post 2.88 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Ancora Advisors LLC Sells 3,510 Shares of Prestige Consumer Healthcare Inc (PBH)” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/12/06/ancora-advisors-llc-sells-3510-shares-of-prestige-consumer-healthcare-inc-pbh.html.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Read More: Should You Consider an Index Fund?
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.